Skip to main content

Dr. Anuja Java, MD

Nephrology (Kidney) (Nephrology Physician)

  • Medicare participating

At a glance

Years since graduation
24
In the NPI registry since
2008
Medicare patients seen, 2024
193

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Nephrology Physician primary
    MO license 2009001291

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Nephrology (Kidney) per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
193
Services billed
478
Patients’ average age
61
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes13353
Established patient office or other outpatient visit, 40-54 minutes10294
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes6830
Urinalysis, manual test5843
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2827
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2222

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 4 companies reported 27 payments worth $78,221 in total to this clinician.

By company
Alexion Pharmaceuticals, Inc.$59,434
Novartis Pharmaceuticals Corporation$15,289
Apellis Pharmaceuticals, Inc.$3,252
Calliditas Therapeutics US Inc.$246
By type
Consulting Fee$41,273
Compensation for services other than consulting (speaking, faculty)$20,435
Travel and Lodging$15,658
Food and Beverage$855

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 5, 2025Alexion Pharmaceuticals, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
SOLIRIS · Rare Disease
Company’s descriptionSpeaker Fee
$20,435
Jun 26, 2025Alexion Pharmaceuticals, Inc.
Jun 26, 2025
Consulting Fee$16,080
May 15, 2025Alexion Pharmaceuticals, Inc.
May 15, 2025
Travel and Lodging
SOLIRIS · Rare Disease · travel to Tokyo, Japan · in-kind
Company’s descriptionSpeaker Expenses
$12,395
Oct 22, 2025Novartis Pharmaceuticals Corporation
Oct 22, 2025
Consulting Fee
Fabhalta · Immunology
$10,000
Dec 1, 2025Alexion Pharmaceuticals, Inc.
Dec 1, 2025
Consulting Fee$5,695
Aug 4, 2025Apellis Pharmaceuticals, Inc.
Aug 4, 2025
Consulting Fee$3,068
Sep 18, 2025Novartis Pharmaceuticals Corporation
Sep 18, 2025
Consulting Fee$3,000
Dec 10, 2025Alexion Pharmaceuticals, Inc.
Dec 10, 2025
Consulting Fee
ULTOMIRIS · Rare Disease
$2,680
May 18, 2025Alexion Pharmaceuticals, Inc.
May 18, 2025
Travel and Lodging
SOLIRIS · Rare Disease · travel to Tokyo, Japan · in-kind
Company’s descriptionSpeaker Expenses
$1,436
Oct 2, 2025Novartis Pharmaceuticals Corporation
Oct 2, 2025
Travel and Lodging
travel to Morristown, NJ · in-kind
$852
All 15 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 10, 2025Alexion Pharmaceuticals, Inc.
Dec 10, 2025
Consulting Fee
ULTOMIRIS · Rare Disease
$2,680
Dec 8, 2025Novartis Pharmaceuticals Corporation
Dec 8, 2025
Consulting Fee
Fabhalta · Immunology
$750
Dec 1, 2025Alexion Pharmaceuticals, Inc.
Dec 1, 2025
Consulting Fee$5,695
Oct 29, 2025Novartis Pharmaceuticals Corporation
Oct 29, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ
$88.85
Oct 22, 2025Novartis Pharmaceuticals Corporation
Oct 22, 2025
Consulting Fee
Fabhalta · Immunology
$10,000
Oct 3, 2025Novartis Pharmaceuticals Corporation
Oct 3, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ · in-kind
$297
Oct 3, 2025Novartis Pharmaceuticals Corporation
Oct 3, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ
$114
Oct 2, 2025Novartis Pharmaceuticals Corporation
Oct 2, 2025
Travel and Lodging
travel to Morristown, NJ · in-kind
$852
Sep 18, 2025Novartis Pharmaceuticals Corporation
Sep 18, 2025
Consulting Fee$3,000
Aug 4, 2025Apellis Pharmaceuticals, Inc.
Aug 4, 2025
Consulting Fee$3,068
Jun 26, 2025Alexion Pharmaceuticals, Inc.
Jun 26, 2025
Consulting Fee$16,080
Jun 5, 2025Alexion Pharmaceuticals, Inc.
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
SOLIRIS · Rare Disease
Company’s descriptionSpeaker Fee
$20,435
May 18, 2025Alexion Pharmaceuticals, Inc.
May 18, 2025
Travel and Lodging
SOLIRIS · Rare Disease · travel to Tokyo, Japan · in-kind
Company’s descriptionSpeaker Expenses
$1,436
May 16, 2025Alexion Pharmaceuticals, Inc.
May 16, 2025
Travel and Lodging
SOLIRIS · Rare Disease · travel to Tokyo, Japan · in-kind
Company’s descriptionSpeaker Expenses
$476
May 15, 2025Alexion Pharmaceuticals, Inc.
May 15, 2025
Travel and Lodging
SOLIRIS · Rare Disease · travel to Tokyo, Japan · in-kind
Company’s descriptionSpeaker Expenses
$12,395

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Missouri →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $17,974 in research payments for these studies, mostly to the institutions running them.

  • A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy
    Novartis Pharmaceuticals Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Nephrology (Kidney) clinicians in Saint Louis

Sources

NPI registry (CMS NPPES, November 2026; record last updated September 8, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1821263559. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.